高级检索
当前位置: 首页 > 详情页

A Prognostic Score for Nasopharyngeal Carcinoma with Bone Metastasis: Development and Validation from Multicenter

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People’s Republic of China [2]State Key Laboratory of Oncology in South China [3]Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of China [4]Department of Oncology, The affiliated hospital of Luzhou medical college, Luzhou, People’s Republic of China [5]Department of Radiation Oncology, The first affiliated hospital of Bengbu medical college, Bengbu, People’s Republic of China [6]Department of Radiation Oncology, Anhui Provincial Hospital, Hefei, People’s Republic of China [7]Department of Radiation Oncology, The people’s hospital of Guangxi zhuang autonomous region, Nanning, People’s Republic of China [8]Department of Medical Oncology, Sichuan Cancer Hospital and Institute, Chengdu, People’s Republic of China [9]Departments of Medical Imaging and Interventional Radiology, Sun Yat-sen University Cancer Center, Guangzhou, People’s Republic of China
出处:
ISSN:

关键词: Prognostic score nasopharyngeal carcinoma bone metastasis validation multicenter

摘要:
Background: To establish a prognostic score based on clinical routine factors to stratify nasopharyngeal carcinoma patients with bone metastasis into risk groups with different survival rates. Materials and Methods: Total 276 patients from multicenter were retrospectively analyzed. Kaplan-Meier method and Cox regression were used to confirm independent risk factors, which were checked for internal validity by bootstrapping method. The prognostic score, deriving from the corresponding regression coefficients in Cox model, classified patients into low and high risk groups. Finally, two independent cohorts were used for external validation. Results: In development cohort, six risk factors were identified: age > 46 year-old (point=1), N> 0 stage (point=2), anemia (point=2), bone metastasis free interval <= 12 months (point=1), without radiotherapy to primary sites (point=1), and without radiotherapy to first metastasis sites (point=1). The derived prognostic score divided patients into low (score, 0-4) and high (score, 5-8) risk groups, with highly significant differences of 5-year overall survival rates (high vs. low risk: 24.6% vs. 58.2%, HR 3.47, P<0.001). Two external validations presented congruent results. Conclusion: A feasible and applicative prognostic score was successfully established and validated to discriminate bone metastatic nasopharyngeal carcinoma into low/high risk groups, which will be useful for individual treatment.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2018]版:
大类 | 3 区 医学
小类 | 3 区 肿瘤学
最新[2023]版:
大类 | 3 区 医学
小类 | 4 区 肿瘤学
JCR分区:
出版当年[2018]版:
Q2 ONCOLOGY
最新[2023]版:
Q2 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2018版] 出版当年五年平均 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者机构: [1]Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People’s Republic of China [2]State Key Laboratory of Oncology in South China
通讯作者:
通讯机构: [1]Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People’s Republic of China [2]State Key Laboratory of Oncology in South China [*1]651 Dongfeng Road East, Guangzhou 510060, People’s Republic of China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:46667 今日访问量:3 总访问量:3332 更新日期:2024-11-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号